Accelerate Diagnostics, Inc. (BMV:AXDX)
1.750
0.00 (0.00%)
At close: May 13, 2025
Accelerate Diagnostics Revenue
In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M USD, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.
Revenue
$11.70M
Revenue Growth
-2.99%
P/S Ratio
0.02
Revenue / Employee
$109.33K
Employees
107
Market Cap
5.01M MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.70M | -361.00K | -2.99% |
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Wal-Mart de México | 972.31B |
Grupo Financiero Banorte | 131.20B |
Arca Continental | 245.87B |
GMéxico Transportes | 61.50B |
FIBRA Prologis | 11.79B |
Fibra UNO | 29.47B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 18.37B |
Becle | 44.63B |